AI assistant
Sending…
REVELATION BIOSCIENCES, INC. — Director's Dealing 2025
Feb 14, 2025
35471_dirs_2025-02-13_4dc0311c-6b7b-43a7-a92e-cee08cf6b576.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REVELATION BIOSCIENCES, INC. (REVB)
CIK: 0001810560
Period of Report: 2025-02-11
Reporting Person: CARVER JENNIFER (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-11 | Common Stock | A | 181 | $3.87 | Acquired | 187 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6 | Direct |
Footnotes
F1: Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests 100% on date of grant.
More from REVELATION BIOSCIENCES, INC.
Proxy Solicitation & Information Statement
2026
May 11
Annual Report
2026
May 11
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Mar 19
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Proxy Solicitation & Information Statement
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Regulatory Filings
2026
Feb 11
Director's Dealing
2026
Feb 5